Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN
08949-cover-7nibrcxd.jpg

December 5, 2011 Cover

Volume 89, Issue 49

A near record high in new drug approvals fortifies the pharmaceutical industry ahead of next year’s patent expiries

Cover image:

Credit:

Full Article
Volume 89 | Issue 49

All Issues

Business

Before The Storm

A near record high in new drug approvals fortifies the pharmaceutical industry ahead of next year’s patent expiries

  • Scientists Are Doing Their Most Creative Work Later In Life

    Study finds in the latter 20th century, Nobel Laureates are more likely to do their prizewinning work after age 40

  • Amyris Hits The Market

    The biochemical start-up is shipping farnesene and expanding its technical and commercial plans

  • Replacing The Replacements

    Governments, industry grapple with potent greenhouse gas effects of widely used non-ozone-depleting refrigerants

ADVERTISEMENT
image name
Materials

Coating By Candlelight

Soot serves as a nanostructured template to create superamphiphobic material

ADVERTISEMENT
ADVERTISEMENT